The latest news from the global pharmaceutical industry. Below you will find news and information to keep you up-to-date with what is happening in your industry. Coverage includes regulatory approvals, recall announcements, mergers and acquisitions, personnel news and appointments, new facility and facility expansion updates, collaborations and agreements, and financial updates.
Wednesday, March 11, 2020
International Pharmaceutical Expo (INTERPHEX) will be postponed due to the COVID-19 virus.
read more
Mylan announced the launch of Wixela Inhub, the first available bioequivalent alternative to ADVAIR DISKUS in Canada.
read more
Hikma Pharmaceuticals USA is voluntarily extending its previously-announced recall of certain lots of Ketorolac Tromethamine Injection USP 30mg/mL, ...
read more
ANI received approval of the Company's ANDA from the FDA for Memantine Hydrochloride Extended-Release Capsules 7 mg, 14 mg, 21 mg and 28 mg.
read more
Thursday, February 27, 2020
Halozyme announced the FDA has accepted a BLA from Genentech for the fixed-dose combination of Perjeta and Herceptin for subcutaneous administration ...
read more
Thursday, February 27, 2020
Oramed announced positive topline data from the second and final cohort of its Phase 2b trial evaluating its lead oral insulin candidate, ORMD-0801, ...
read more
Wednesday, February 26, 2020
CPhI Japan has announced the event will be postponed until a new date later in the year after consultation with key stakeholders and consideration of ...
read more
Wednesday, February 26, 2020
Perrigo and Catalent Pharma Solutions announced the FDA has approved Perrigo’s ANDA for generic albuterol sulfate inhalation aerosol.
read more
Tuesday, February 25, 2020
The FDA approved the first generic of ProAir HFA (albuterol sulfate) Inhalation Aerosol.
read more
Monday, February 24, 2020
United Therapeutics and DEKA announced receipt of an additional 510(k) clearance by the FDA related to the Unity Subcutaneous Delivery System for ...
read more
Monday, February 24, 2020
Teva Respiratory announced the FDA has approved ArmonAir Digihaler Inhalation Powder, an inhaled corticosteroid delivered via Digihaler device for ...
read more
Friday, February 21, 2020
Companion Medical announced clearance by the FDA for the use of Novo Nordisk's Fiasp® rapid-acting insulin.
read more
Wednesday, February 19, 2020
Diasome announced positive results from its Phase 2 OPTI-1 study of injectable hepatocyte directed vesicle added to mealtime insulin in people with ...
read more
Friday, February 14, 2020
Avenue Therapeutics announced the FDA has accepted for review Avenue’s NDA for IV tramadol for the management of moderate to moderately severe pain in...
read more
Tuesday, February 11, 2020
Oculis reports positive data from a phase 2 study of OCS-01, a novel eye drop formulation of dexamethasone, in development for the treatment of ...
read more